Podiatrist, Foot & Ankle Surgery · Brooklyn, NY
NPI
1306129341
Since 2011
Specialty
Podiatrist, Foot & Ankle Surgery
Code 213ES0103X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
1545 Atlantic Ave
Brooklyn, NY, 11213
Phone (718) 613-7005
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
531 services
Medicare patients, 2024
195
Average age 73
Drug cost, 2024
$688K
1,365 prescriptions
Company payments, 2025
$18K
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Olatunde Osofisan was code 99213 (office e&m - established), 144 times for 83 patients. In total Olatunde Osofisan billed 531 services in 34 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-09-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 144 | 83 | $80.47 | $12K |
| 99213 Office E&M - Established | Facility | 117 | 69 | $51.13 | $5,982 |
| 11721 Nail Procedure | Office | 58 | 48 | $40.49 | $2,348 |
| 11056 Removal or Shaving of Skin Growth | Office | 27 | 25 | $73.26 | $1,978 |
| 99203 Office E&M - New | Office | 22 | 22 | $101.41 | $2,231 |
By year: 2022 $50K for 759 services; 2023 $91K for 1,292 services; 2024 $86K for 531 services.
Medicare prescription drug claims, 2024
In 2024, the drug Olatunde Osofisan prescribed most often to Medicare patients was Clobetasol Propionate, with 294 prescriptions and refills. In total Olatunde Osofisan wrote 1,365 Medicare prescriptions that cost $688K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clobetasol Propionate Generic | 294 | 462 | 95 | $138K |
| Caspofungin Acetate Generic | 208 | 208 | 78 | $52K |
| Doxepin Hcl Generic | 154 | 167 | 90 | $115K |
| Diflorasone Diacetate Generic | 98 | 115 | 46 | $68K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 95 | 95 | 38 | $24K |
| Betamethasone Dipropionate Generic | 62 | 85 | 20 | $12K |
| Tavaborole Generic | 48 | 48 | 22 | $12K |
| Budesonide Er Budesonide | 40 | 40 | 15 | $48K |
| Desoximetasone Generic | 31 | 31 | 13 | $8,763 |
| Fluocinonide Generic | 27 | 32 | 15 | $10K |
| Ammonium Lactate Generic | 26 | 26 | 17 | $596 |
| Ertaczo Sertaconazole Nitrate | 24 | 24 | 11 | $40K |
| Fluocinolone Acetonide Oil Generic | 21 | 21 | 13 | $3,643 |
| Chlorpromazine Hcl Generic | 21 | 21 | 11 | $17K |
| Oxiconazole Nitrate Generic | 20 | 20 | Under 11 | $11K |
Brand drugs: 267 claims; generic drugs: 1,098 claims; opioid claims: 23.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Olatunde Osofisan $18K ($18K in general payments such as food, travel and fees) from 16 companies. The largest payer was Novastep Inc. with $6,694.
| Company | Payments | Amount |
|---|---|---|
| Novastep Inc. | 2 | $6,694 |
| Treace Medical Concepts, Inc. TMCI | 12 | $2,622 |
| Stryker Corporation SYK | 26 | $2,264 |
| Acumed LLC | 12 | $2,075 |
| Abbott Laboratories ABT | 8 | $1,096 |
| Aroa Biosurgery Incorporated ARX.AX | 9 | $729 |
| Linvatec Corporation CNMD | 4 | $524 |
| PolyNovo North America LLC | 4 | $511 |
| Shockwave Medical, Inc JNJ | 2 | $366 |
| Djo, LLC ENOV | 5 | $243 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.